. >> their earnings are decelebrating and and it's rather high. they're going to nail it. and the second is gilead's earnings are due out next week. i wonder if that's the escape into earnings. >> they have to be able to show what they're going to do with their cash because the hep c drug is generating so much of it. we get even more dayta about that alzheimer's drug and then we have the number that's not so hot. every time these stocks get hit, they have something else in the pipe. i say biogen it's okay. after down 28 day. it tends to be down. 350, 360, that's where you buy. >> stop signing about earnings. we have great reports today and they made you real money. get ready for more next week. i think you have to buy some of these in weakness too. mad money tonight looking for a way to play oil and gas, don't miss it right off of earnings beat. are all of the rallies the real deal? don't miss my take. plus a stock helping companies make sense of huge amounts of data. i say stick with my apple watch which you'll need a saw to -- oh, okay. stick with cramer. >> have a quest